NPHP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.833820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.498400E-01
Normal-vs-Stage2
2.106400E-01
Normal-vs-Stage3
2.132800E-01
Normal-vs-Stage4
8.623000E-01
Stage1-vs-Stage2
5.014000E-01
Stage1-vs-Stage3
4.409600E-02
Stage1-vs-Stage4
6.515200E-01
Stage2-vs-Stage3
8.968800E-04
Stage2-vs-Stage4
2.677200E-01
Stage3-vs-Stage4
1.018650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.072600E-01
Normal-vs-AfricanAmerican
2.571200E-01
Normal-vs-Asian
1.078210E-01
Caucasian-vs-AfricanAmerican
5.758400E-01
Caucasian-vs-Asian
1.114630E-01
AfricanAmerican-vs-Asian
6.039800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.739400E-01
Normal-vs-Female
2.216200E-01
Male-vs-Female
7.780800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.591600E-01
Normal-vs-Age(41-60Yrs)
3.344400E-01
Normal-vs-Age(61-80Yrs)
1.576810E-01
Normal-vs-Age(81-100Yrs)
8.769500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.386400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.538400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.373970E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.130200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.411800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.946400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.461960E-01
Normal-vs-Daily Drinker
1.089830E-01
Normal-vs-Weekly Drinker
1.774610E-01
Normal-vs-Occasional Drinker
3.419800E-01
Normal-vs-Social Drinker
5.935000E-01
Non Drinker-vs-Daily Drinker
9.146400E-01
Non Drinker-vs-Weekly Drinker
8.638400E-01
Non Drinker-vs-Occasional Drinker
6.664000E-01
Non Drinker-vs-Social Drinker
1.088200E-01
Daily Drinker-vs-Weekly Drinker
7.845000E-01
Daily Drinker-vs-Occasional Drinker
7.669200E-01
Daily Drinker-vs-Social Drinker
9.040000E-02
Weekly Drinker-vs-Occasional Drinker
5.605000E-01
Weekly Drinker-vs-Social Drinker
2.052200E-01
Occasional Drinker-vs-Social Drinker
5.833900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.314230E-01
Normal-vs-Grade 2
2.628000E-02
Normal-vs-Grade 3
1.837600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.403800E-01
Grade 1-vs-Grade 3
3.485200E-01
Grade 1-vs-Grade 4
1.314230E-01
Grade 2-vs-Grade 3
9.067600E-01
Grade 2-vs-Grade 4
2.628000E-02
Grade 3-vs-Grade 4
1.837600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.472200E-02
Normal-vs-NonDiabetic
1.640370E-01
Diabetic-vs-NonDiabetic
3.275400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.060200E-01
Normal-vs-NoPancreatitis
1.071230E-01
Pancreatitis-vs-NoPancreatitis
6.147200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.933380E-01
Normal-vs-N1
1.919200E-01
N0-vs-N1
5.773600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.088160E-01
Normal-vs-TP53-NonMutant
2.986800E-01
TP53-Mutant-vs-TP53-NonMutant
2.909800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
